Archives of Physiology and Biochemistry · 2020 · 12 citations · 25 references
Veterinary MedicinePathobiologyCell TherapyHepatologyInflammationBiomarkers Of Liver InjuryFibrosisHepatic FibrosisLiver DiseaseLiver Function TestsLiver RegenerationCarbon Tetrachloride HepatotoxicityEndothelial Progenitor CellsHepatic Fibrosis BiomarkersImmunohistochemistry AssaysLiver Fibrosis BiomarkersLiver Fibrosis ProgressionLiver Regeneration ModelsProgenitor Cells
Background We speculated impacts of BM-MSCs and UC-EPCs on reversal of hepatic injury induced by carbon tetrachloride (CCl4). Fifty adult rats were divided into five groups: control group, CCl4A group, CCl4B group, CCl4/BM-MSCs group and CCl4/UC-EPCs group. Blood samples were driven to measure concentration of albumin and ALT. Quantitative expression of HGF, TGF-β, MMP-2, and VEGF were assessed by PCR. Histological and immunohistochemistry examination of the liver tissue were performed.Results There was elevating albumin (p < .05) and reducing ALT (p < .05) concentrations in groups treated with BM-MSCs and UC-EPCs compared to untreated CCL4A&B groups. UC-EPCs treated group have significantly higher MMP-2 and VEGF (p < .01) genes expression than BM-MSCs treated group. Furthermore, UC-EPCs were more valuable than BMMSCs in increasing gene expression of HGF (p < .05) and immunohistochemistry of α-SMA and Ki-67 (p < .01). BM-MSCs have significantly lower TGF-β (p < .00) compared to UC-EPCs.Conclusion This study highlighted on liver regeneration role of both UC-EPCs and BM-MSCs in liver fibrosis.
25
Biostatistics 102: quantitative data--parametric & non-parametric tests.
Pedram Kharaziha, Per M. Hellström, Babak Noorinayer et al. · European Journal of Gastroenterology & Hepatology · 2009 · 504 citations